Search Results
, & Keshavan, 2009 ). Improving the treatment for this debilitating disease would benefit individuals who struggle with this chronic disease and their families. Given that there is a renewed interest in using psychedelics to treat a wide variety of conditions
With the advancement of psychedelic science into the forefront of global consciousness, research continues to affirm the promise of psychedelic medicines to aid in the healing of those suffering from trauma, addiction, depression, anxiety
Introduction Researchers have called attention to the ways that the hype promoting psychedelics as miracle cures replicates preceding claims about the efficacy of SSRIs and other antidepressants in prior decades. As the drug historian David Herzberg
Introduction The so-called classical psychedelics, or serotonergic hallucinogens, include mainly lysergic acid diethylamide (LSD), psilocybin, mescaline, dimethyltryptamine (DMT), and methoxy-N,N-dimethyltryptamine (5-MeO
stigma towards people with SUDs ( Adlaf et al., 2009 ). Thus, it seems possible that social proximity and personal use of specific drugs may have unique effects on overall attitudes towards drugs and people who use them. Psychedelic drugs are unique as
Introduction The last twenty years of research on psychedelics has observed long-term effects on mental health (e.g., Carhart-Harris et al., 2018 ; Gukasyan et al., 2022 ), personality ( Erritzoe et al., 2018 ; Netzband, Ruffell, Linton, Tsang
Introduction The term ‘psychedelic’ refers to a range of hallucinogenic compounds that induce altered states of consciousness ( Garcia-Romeu, 2016 ). Broadly speaking, these compounds can be categorised into four
Introduction Serotonergic (or “classic”) psychedelics are the objects of renewed scientific interest. These psychoactive substances can induce dramatic changes to perception, cognition, and emotion, primarily via
research exploring novel pharmacologic drugs for this vulnerable population. Therefore, the primary aim of this observational study is to assess whether psychedelic treatment with ibogaine and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is associated with
psychedelics in the treatment of psychiatric conditions, such as treatment resistant depression, post-traumatic stress disorder (PTSD), and depression ( Carhart-Harris et al., 2016 ; Carhart-Harris & Goodwin, 2017 ; Mithoefer, Grob, & Brewerton, 2016 ; Sessa
